-
Sustainable material to regenerate cartilage damage
A team in the Department of Chemical and Environmental Engineering at the EHU-University of the Basque Country and which is part of the BIOMAT group has developed structures for cartilage regeneration based on cellulose, gelatin and soy proteins with promising mechanical and biological properties.On : 31-Jul-2026- Source : HealthCareEurope -
Construction of biomimetic gradientstructured cartilage organoids and mechanistic study of their application for cartilage rejuvenation
Owing to the lack of blood vessels and nerves and the limited number of chondrocytes in articular cartilage, cartilage repair has long been a topic of interest and a clinical challenge worldwideOn : 31-Jul-2026- Source : ScienceDirect -
Targeted Therapy Shows Promising Results Against Rare Soft Tissue Sarcoma
Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now a clinical trial led by doctors from Memorial Sloan Kettering Cancer Center (MSK) has found that abemaciclib (Verzenio®) - a drug already approved for certain breast cancers...On : 31-Jul-2026- Source : MSKCC -
New Options for Adolescent and Young Adult Patients with Sarcoma
Sarcomas are cancers that occur in bone or soft tissue, such as muscles and fat. These cancers are rare and diverse, with more than 150 different variations.On : 31-Jul-2026- Source : Dana-Farber -
Why Sarcoma Diagnosis Often Takes Time and Why Specialist Access Matters Alexander Spira MD PhD FACP FASCO
Spira notes that delayed sarcoma diagnoses are not typically the result of physician error but rather just due to the nature of the condition. Because sarcomas arise in muscle and soft tissue, early symptoms can resemble a common strain or minor injury, leading patients to be reassured or treated co...On : 31-Jul-2026- Source : AJMC -
FDA Grants Full Approval to Engineered Cell Therapy for Treating Rare Sarcoma
Afami-cel dramatically shrank sarcoma tumors in almost half of patients participating in a clinical trial, led by Memorial Sloan Kettering Cancer Center (MSK) sarcoma specialist and immunotherapy expert Sandra D’Angelo, MD.On : 31-Jul-2026- Source : MSKCC -
Advanced synthetic grafting material fights bone cancer and prevents infection
Primary bone tumors, such as osteosarcoma, have seen stagnant survival rates over the past four decades. Surgical removal of the tumor is critical, but local recurrence may occur when tumours are close to vital structures, often resulting in amputation.On : 31-Jul-2026- Source : NewsMedical -
Stopping Ewing sarcoma relapses where they start
Two new drugs show promise in treating relapsed Ewing sarcoma, as new studies from University of Michigan Health Rogel Cancer Center researchers report.On : 31-Jul-2026- Source : MichiganMedicine -
Hip Arthroscopic Labral Repair with Transcapsular Suture Passage for Medial Capsular Preservation
As the prevalence of hip arthroscopy increases, so has the role of capsular management. Biomechanical studies have shown that a capsulotomy restores the native biomechanics and rotation profile of the hip.2,4 Recent clinical studies have also shown that capsular closure at the time of primary hip ar...On : 31-Jul-2026- Source : ScienceDirect -
Temporospatial Parameters and Gait Symmetry in Hip Pathology Patients Pre and Post Hip Preservation Surgery
Patients presenting for surgery have statistically significant deficits in temporospatial parameters when compared to their unimpaired peers though many of these differences could be considered to not be clinically significant. Patients with previous surgery or diagnosed with unilateral involvement ...On : 31-Jul-2026- Source : ScienceDirect

